Advertisement

Gastrointestinale Probleme beim Intensivpatienten

  • Hans-Dieter Allescher
  • Wolfram Reeker
Living reference work entry
Part of the Springer Reference Medizin book series (SRM)

Zusammenfassung

Der Gastrointestinaltrakt ist ein komplexes Organsystem, das neben der Verarbeitung und Resorption von Nährstoffen wichtige Barrierefunktionen besitzt. Viele Medikamente, die im Bereich Anästhesie, Intensivmedizin, Notfallmedizin und Schmerztherapie eingesetzt werden, haben Auswirkungen auf das gastrointestinale Mikrobiom, die Motilität, die Sekretion und die Durchblutung des Gastrointestinaltrakts. Im Rahmen der Intensivbehandlung spielen insbesondere prolongierte postoperative bzw. posttraumatische Motilitätsstörungen eine Rolle, die die Möglichkeit einer enteralen Ernährung beeinträchtigen und die Translokation von Darmkeimen begünstigen. Dies kann zur Entwicklung septischer Komplikationen bis hin zum Multiorganversagen führen.

Literatur

  1. 1.
    Deane A, Chapman MJ, Fraser R et al (2007) Mechanismus underlying feed intolerance in the critically ill: implications for treatment. World J Gastroenterol 13:3909–3917CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Lin HC, Van Citters GW (1997) Stopping enteral feeding for arbitrary gastric residual volume may not be physiological sound: results of a computer simulation model. JPEN J Parenter Enteral Nutr 21:286–289CrossRefPubMedGoogle Scholar
  3. 3.
    Van Bree S, Vlug M, Bemelman W et al (2011) Faster recovery of gastrointestinal transit after laparoscopy and fast-track care in patients undergoing colonic surgery. Gastroenterology 141:872. Epub May 2011CrossRefPubMedGoogle Scholar
  4. 4.
    Chappell D, Conzen P (2009) Methylnaltrexone. A new approach for therapy of opioid induced obstipation. Schmerz 23:471–478CrossRefPubMedGoogle Scholar
  5. 5.
    Woo M, O’Connor M, Yuan CS, Moss J (2008) Reversal of opioid-induced gastric dysfunction in a critically ill burn patient after methylnaltrexone. Anesth Analg 107:1965–1967CrossRefPubMedGoogle Scholar
  6. 6.
    Lee N, Wald A (2011) The pharmacokinetics, pharmacodynamics, clinical efficacy, safety and tolerability of linaclotide. Expert Opin Drug Metab Toxicol 7(5):651–659CrossRefPubMedGoogle Scholar
  7. 7.
    Kapoor S (2009) Lubiprostone: clinical applications beyond constipation. World J Gastroenterol 15(9):1147CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Lee CH, Steiner T, Petrof EO, Smieja M, Roscoe D, Nematallah A, Weese JS, Collins S, Moayyedi P, Crowther M, Ropeleski MJ, Jayaratne P, Higgins D, Li Y, Rau NV, Kim PT (2016) Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium difficile infection: a randomized clinical trial. JAMA 315(2):142–149CrossRefPubMedGoogle Scholar
  9. 9.
    Surawicz C (1989) Prevention of antibiotic-assiciated diarrhea by Sacharomyces boulardii: a prospective study. Gastroenterology 96:981–988CrossRefPubMedGoogle Scholar
  10. 10.
    Cook DJ, Guyatt G, Marshall J et al (1998) A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med 338:791–797CrossRefPubMedGoogle Scholar
  11. 11.
    Matamis D (1999) Prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Intensive Care Med 25:118–119CrossRefPubMedGoogle Scholar
  12. 12.
    Kallet RH, Quinn TE (2005) The gastrointestinal tract and ventilator-associated pneumonia. Respir Care 50:910–921PubMedGoogle Scholar
  13. 13.
    Metz DC (2005) Preventing the gastrointestinal consequences of stress-related mucosal disease. Curr Med Res Opin 21:11–18CrossRefPubMedGoogle Scholar
  14. 14.
    Cook DJ, Fuller HD, Guyatt GH et al (1994) Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trial Group. N Engl J Med 330:337CrossRefGoogle Scholar
  15. 15.
    Cook DJ, Griffith LE, Walter SD et al (2001) The attributable mortality and length of intestinal care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care 5:368CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Maury E, Tankovic J, Ebel A et al (2005) An observational study of upper gastrointestinal bleeding in intensive care units: is Helicobacter pylori a culprit? Crit Care Med 33:1513CrossRefPubMedGoogle Scholar
  17. 17.
    Stollman N, Metz DC (2005) Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients. J Crit Care 20:35–45CrossRefPubMedGoogle Scholar
  18. 18.
    Tryba M (1991) Sucralfate versus antacids or H2-antagonists for stress ulcer prophylaxis: a meta-analysis on efficacy and pneumonia rate. Crit Care Med 19:942–949CrossRefPubMedGoogle Scholar
  19. 19.
    Pickworth KK, Falcone RE, Hoogeboom JE, Santanello SA (1993) Occurence of nosocomial pneumonia in mechanically ventilated trauma patients: a comparison of sucralfate and ranitdine. Crit Care Med 21:1856–1862CrossRefPubMedGoogle Scholar
  20. 20.
    Prod’hom G, Leuenberger P, Koerfer J et al (1994) Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. A randomized controlled trial. Ann Intern Med 120:653–662CrossRefPubMedGoogle Scholar
  21. 21.
    Raff T, Germann G, Hartmann B (1997) The value of early enteral nurtrion in the prophylaxis of stress ulceration in severly burned patients. Burns 23:313CrossRefGoogle Scholar
  22. 22.
    Lasky MR, Metzler MH, Phillips JO (1998) A prospective study of omeprazole suspension to prevent clinically significant gastrointestinal bleeding from stress ulcers in mechanically ventilated trauma patients. J Trauma 44:527–533CrossRefPubMedGoogle Scholar
  23. 23.
    Devlin JW, Welage LS, Olson KM (2005) Proton pump inhibitor formulary considerations in the acutely ill. Part 2: clinical efficacy, safety and economics. Ann Pharmacother 39:1844–1851CrossRefPubMedGoogle Scholar
  24. 24.
    Lu WY, Rhoney DH, Boling WB, Johnson JD, Smith TC (1997) A review of stress ulcer prophylaxis in the neurosurgical intensive care unit. Neurosurgery 41:416–425CrossRefPubMedGoogle Scholar
  25. 25.
    Zandstra DF, Stoutenbeek CP (1994) The virtual absence of stress-ulzeration related bleeding in ICU patients receiving prolonged mechanical ventilation without any prophylaxis. A prospective cohort study. Intensive Care Med 20:335–240CrossRefPubMedGoogle Scholar
  26. 26.
    Steinberg KP (2002) Stress-related mucosal disease in the critically ill patient: risk factors and strategies to prevent stress-related bleeding in the intensive care unit. Crit Care Med 30:S262–S364CrossRefGoogle Scholar
  27. 27.
    Kalliafas S, Ziegler DW, Flancbaum L, Choban PS (1998) Acute acalculous cholecystitis: incidence, risk factors, diagnosis, and outcome. Am Surg 64:471–475PubMedGoogle Scholar
  28. 28.
    Raunest J, Imhof M, Rauen U et al (1992) Acute cholecystitis: a complication in severely injured intensive care patients. J Trauma 32:433–440CrossRefPubMedGoogle Scholar
  29. 29.
    Gelbmann CM, Rümmele P, Wimmer M et al (2007) Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients. Am J Gastroenterol 102:1221–1229CrossRefPubMedGoogle Scholar
  30. 30.
    Rümmele P, Hofstädter F, Gelbmann CM (2009) Secondary sclerosing cholangitis. Nat Rev Gastroenterol Hepatol 6:287–295CrossRefGoogle Scholar
  31. 31.
    Kirchner GI, Scherer MN, Obed A et al (2011) Outcome of patients with schemic-like cholangiopathy with secondary sclerosing cholangitis after liver transplantation. Scand J Gastroenterol 46:471–478CrossRefPubMedGoogle Scholar

Copyright information

© © Springer-Verlag GmbH Deutschland 2018

Authors and Affiliations

  1. 1.Klinikum Garmisch-Partenkirchen, Zentrum für Innere Medizin, Gastroenterologie, Hepatologie und StoffwechselGarmisch-PartenkirchenDeutschland
  2. 2.Luisenhospital Aachen, Klinik für Anästhesiologie und operative IntensivmedizinAachenDeutschland

Section editors and affiliations

  • Rolf Rossaint
    • 1
  1. 1.Klinik für operative Intensivmedizin und Intermediate CareUniversitätsklinikum AachenAachenDeutschland

Personalised recommendations